- active not recruitingPHASE2
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
This study is looking into a new medication called ESK-001 for adults with an active form of lupus (SLE). We want to see if it's safe and helps improve symptoms compared to a dummy drug (placebo).
United States · Argentina · Bulgaria - recruitingPHASE2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
This study is testing a new medicine, VENT-03, for adults with a skin condition called cutaneous lupus (CLE), who may also have systemic lupus (SLE). Researchers want to see if VENT-03 helps reduce symptoms and if it's safe.
United States · Bulgaria · France